Primary Central Nervous System Vasculitis with Prominent Leptomeningeal Enhancement
Arthritis Rheum:58:595-603, Salvarani, C.,et al, 2008
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Autoimmune Encephalopathies
The Neurologist 13:140-147, Vernino, S.,et al, 2007
MR Imaging, Diffusion-Weighted Imaging and MR Spectroscopy Findings in Acute Rapidly Progressive Subacute Sclerosing Panencephalitis
Brain Dev 29:306-311, Oguz, K.K.,et al, 2007
Course of Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 68:1411-1416, Kinnecom,C.,et al, 2007
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007
Fatal Encephalopathy After an Isolated Overdose of Cocaine
JNNP 78:437-438, Kondziella,D., et al, 2007
Extensive White Matter Injury in Hypoglycemic Coma
Neurol 68:1074, Kim,J. &Koh,S., 2007
Misdiagnosis of stroke
Expert Rev Neurother 7:989-1001, Nor, A.M.,et al, 2007
Pediatric Encephalitis: What Is the Role of Mycoplasma Pneumoniae
Pediatrics 120:305-313, Christie,L.J., et al, 2007
Admission Facility Is Associated With Outcome of Basilar Artery Occlusion
Stroke 38:1380-1383, Muller,R.,et al, 2007
Mechanical Thrombectomy of Intracranial Internal Carotid Occlusion: Pooled Results of the MERCI and Multi MERCI Part I Trials
Stroke 38:1274-1280, Flint,A.C.,et al, 2007
Ischemic and Hemorrhagic Complications After Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion
AJNR 28:378-381, Schulte-Altedorneburg,G.,et al, 2007
Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment
Stroke 38:3213-3217, Juhl,J.,et al, 2007
Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS)
Stroke 38:3121-3126, Khatri,M.,et al, 2007
Central Nervous System Infections in Heart Transplant Recipients
Arch Neurol 64:1715-1720, van de Beek,D.,et al, 2007
Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007
Early Care Limitations Independently Predict Mortality After Intracerebral Hemorrhage
Neurol 68:1651-1657,1647, Zahuranec,D.B.,et al, 2007
Utility of Urinalysis in Discriminating Cardioembolic Stroke Mechanism
Arch Neurol 64:667-670, Viehman,J.A.,et al, 2007
Artery of Percheron Thrombolysis
AJNR 28:870-871, Kostanian,V. &Cramer,S.C., 2007
Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007
Adult-Onset Vanishing White Matter Leukoencephalopathy Presenting as Psychosis
Neurol 68:1538-1539, Denier,C.,et al, 2007
A Young Man with Rapidly Progressive Multifocal Disease Affecting the White matter
Pract Neurol 7:172-181, Hilton-Jones,D.,et al, 2007
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts & Leukoencephalopathy (CADASIL)
UpToDate (www.uptodate.com) Aug 21, Dichgans,M.,et al., 2007
Analysis of Central Nervous System Vasculitis with Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping of the Normal-Appearing Brain
AJNR 28:933-937, White,M.L.,et al, 2007
Congenital Muscular Dystrophy
eMedicine (Jan), Lopate,G., 2007
Phenylketonuria
eMedicine (December), Arnold,G.L., 2007
A 40-Year-Old Woman with Epistaxis, Hematemesis, and Altered Mental Status
NEJM 356:174-182, Case 1-2007, 2007
Outcome of Neonatal Screening for Medium-Chain acyl-CoA Dehydrogenase Deficiency in Australia: A Cohort Study
Lancet 369:37-42,5, Wilcken,B.,et al, 2007
Recanalization After Thrombolysis in Stroke Patients: Predictors and Prognostic Implications
Neurol 68:39-44, Zangerle,A.,et al, 2007
Hemostatic Drug Therapies for Acute, Nontraumatic Intracerebral Hemorrhage
Stroke 38:204-205, Al-Shahi,R. &You,H., 2007
Cost-Effectiveness of Intravenous Thrombolysis With Alteplase Within a 3-Hour Window After Acute Ischemic Stroke
Stroke 38:85-89, Ehlers,L.,et al, 2007
Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke?
Stroke 38:80-84, Shaltoni,H.M.,et al, 2007
Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke 38:7579, Dzialowski,I.,et al, 2007
Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007
Thrombolysis With Alteplase for Acute Ischaemic Stroke in the Safe Implementation of Thrombolysis in stroke-Monitoring Study (SITS-MOST): An Observational Study
Lancet 369:275-282,249, Wahlgren,N.,et al, 2007
Identification of the Penumbra and Infarct Core on Hyperacute Noncontrast and Perfusion CT
Neurol 68:730-736,717, Parsons,M.W.,et al, 2007
Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007
Lacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL
Stroke 38:923-928, Liem,M.K.,et al, 2007
The Safety of Hospital Stroke Care
Neurol 68:550-555,542, Holloway,R.G.,et al, 2007
Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007
Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007
Guidelines for the Early Management of Adults With Ischemic Stroke
Stroke 38:1655-1711, Adams,H.P.,et al, 2007
Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007
Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke 38:1652-1654, Gorelick,P.B., 2007
Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update
Stroke 38:2001-2023, Broderick,J.,et al, 2007
Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007
Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007